Abstract
Objective and methods
In order to better understand the effects of opioids on the cognitive function in cancer pain patients, a literature search was performed in PubMed, EMBASE, PsycInfo, CINAHL and Lilacs databases. Ten controlled trials were selected and classified according to the study design, the level of evidence, and opioid regimen.
Result
Six studies reported association between poor cognitive performance (reaction time, attention, balance, and memory) and opioid use.
Conclusion
These cognitive deficits were captured with neuropsychological tests; however, their clinical relevance is still uncertain.
Similar content being viewed by others
References
Airaksinen E, Larsson M, Lundberg I, Forsel L (2004) Cognitive functions in depressive disorders: evidence from a population-based study. Psychol Med 34(1):83–91. doi:10.1017/S0033291703008559
Airaksinen E, Larsson M, Forsell Y (2005) Neuropsychological functions in anxiety disorders in population-based samples: evidence of episodic memory dysfunction. J Psychiatr Res 39(2):207–214. doi:10.1016/j.jpsychires.2004.06.001
Austin MP, Mitchell P, Goodwin GM (2001) Cognitive deficits in depression: possible implications for functional neuropathology. Br J Psychiatry 178:200–206. doi:10.1192/bjp.178.3.200
Banning A, Sjøgren P (1990) Cerebral effects of long-term oral opioids in cancer patients measured by continuous reaction time. Clin J Pain 6:91–95. doi:10.1097/00002508-199006000-00005
Banning A, Sjøgren P, Kaiser F (1992) Reaction time in cancer patients receiving peripherally acting analgesics alone or in combination with opioids. Acta Anaesthesiol Scand 36:480–482
Barsevick AM, Whitmer K, Nail L, Beck SL, Dudley WN (2006) Symptom cluster research: conceptual, design, measurement, and analysis issue. J Pain Symptom Manage 31(1):85–95. doi:10.1016/j.jpainsymman.2005.05.015
Barsevick AM (2007) The concept of symptom cluster. Semin Oncol Nurs 23(2):89–98. doi:10.1016/j.soncn.2007.01.009
Bender CM, Sereika SM, Berga SL, Vogel VG, Brufsky AM, Paraska KK et al (2006) Cognitive impairment associated with adjuvant therapy in breast cancer. Psychooncology 15:422–430. doi:10.1002/pon.964
Bruera E, Macmillan K, Hanson J, MacDonald RN (1989) The cognitive effects of the administration and narcotic analgesics in patients with cancer pain. Pain 39:13–16. doi:10.1016/0304-3959(89)90169-3
Chapman SL, Byas-Smith MG, Reed BA (2002) Effects of intermediate and long-term use of opioids on cognition in patients with chronic pain. Clin J Pain 18:S83–S90. doi:10.1097/00002508-200207001-00010
Christrup LL, Sjøgren P, Jensen N-H, Banning AM, Elbæk K, Ersbøll AK (1999) Steady-state kinetics and dynamics of morphine in cancer patients: is sedation related to the absorption rate of morphine? J Pain Symptom Manage 18:164–173. doi:10.1016/S0885-3924(99)00068-8
Clemons M, Regnard C, Appleton T (1996) Alertness, cognition and morphine in patients with advanced cancer. Cancer Treat Rev 22:451–468. doi:10.1016/S0305-7372(96)90026-2
de Stoutz ND, Bruera E, Suarez-Almazor M (1995) Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Manage 10:378–384. doi:10.1016/0885-3924(95)90924-C
Derogatis LR, Morrow GR, Fetting J, Penman D, Piasetsky S, Schmale AM et al (1983) The prevalence of psychiatric disorders among cancer patients. JAMA 249:751–757. doi:10.1001/jama.249.6.751
Dodd MJ, Janson S, Facione N, Faucett J, Froelicher ES, Humphreys J et al (2001) Advancing the science of symptom management. J Adv Nurs 33(5):668–676. doi:10.1046/j.1365-2648.2001.01697.x
Elsass P (1986) Continuous reaction times in cerebral dysfunction. Acta Neurol Scand 73:1–22
Ersek M, Cherrier MM, Overman SS, Irving GA (2004) The cognitive effects of opioids. Pain Manag Nurs 5(2):75–93. doi:10.1016/j.pmn.2003.11.002
Falleti MG, Sanfilippo A, Maruff P, Weih L, Phillips KA (2005) The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature. Brain Cogn 59(1):60–70. doi:10.1016/j.bandc.2005.05.001
Fletcher RH, Fletcher SW, Wagner EH (2005) Clinical epidemiology: the essentials, 4th edn. Lippincott Williams & Wilkins, Baltimore
Gronwall D, Wrightson P (1974) Delayed recovery of intellectual function after minor head injury. Lancet 304(7881):605–609. doi:10.1016/S0140-6736(74)91939-4
Jansen CE, Miaskowski C, Dodd M, Dowling G, Kramer J (2005) A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Cancer 104(10):2222–2233. doi:10.1002/cncr.21469
Jensen AR, Rohwer WD Jr (1966) The stroop color-word test: a review. Acta Psychol (Amst) 25:36–93. doi:10.1016/0001-6918(66)90004-7
Kamboj SK, Tookman A, Jones L, Curran HV (2005) The effects of immediate-release morphine on cognitive functioning in patients receiving chronic opioid therapy in palliative care. Pain 117:388–395. doi:10.1016/j.pain.2005.06.022
Klepstad P, Hilton P, Moen, Fougner B, Borchgrevink PC, Kaasa S (2002) Self-reports are not related to objective assessment of cognitive function and sedation in patients with cancer pain admitted to a palliative care unit. Palliat Med 16:513–519. doi:10.1191/0269216302pm587oa
Klepstad P, Borchgrevink PC, Dale O, Zahlsen K, Aamo T, Fayers P et al (2003) Routine drug monitoring of serum concentrations of morphine, morphine-3-glucuronide and morphine-6-glucuronide do not predict clinical observations in cancer patients. Palliat Med 17:679–687
Lawlor PG (2002) The panorama of opioid-related cognitive dysfunction in patients with cancer. Cancer 94(6):1836–1853. doi:10.1002/cncr.10389
Lawlor PG, Gagnon B, Mancini IL, Pereira JL, Hanson J, Suarez-Almazor ME et al (2000) Occurrence, causes, and outcome of delirium in advanced cancer patients: a prospective study. Arch Intern Med 160:786–794. doi:10.1001/archinte.160.6.786
Levine PM, Silberfarb PM, Lipowski ZJ (1978) Mental disorders in cancer patients a study of 100 psychiatric referrals. Cancer 43:1385–1391. doi:10.1002/1097-0142(197809)42:3<1385::AID-CNCR2820420349>3.0.CO;2-0
Lezak MD (1995) Neurobehavioral variables and diagnostic issues. In: Lezak MD (ed) Neuropsychological assessment, 3rd ed. Oxford University Press, New York, pp 277–331
Lorenz J, Beck H, Bromm B (1997) Cognitive performance, mood and experimental pain before and during morphine-induced analgesia in patients with chronic non-malignant pain. Pain 73:369–375. doi:10.1016/S0304-3959(97)00123-1
Massie MJ, Holland J, Glass E (1983) Delirium in terminally ill cancer patients. Am J Psychiatry 140:1048–1050
McCracken LM, Iverson GL (2001) Predicting complaints of impaired cognitive functioning in patients with chronic pain. J Pain Symptom Manage 21(5):392–396. doi:10.1016/S0885-3924(01)00267-6
McNamara P (2002) Opioid switching from morphine to transdermal fentanyl for toxicity reduction in palliative care. Palliat Med 16:425–434. doi:10.1191/0269216302pm536oa
Mercadante S, Casuccio A, Fulfaro F, Groff L, Boffi R, Villari P et al (2001) Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study. J Clin Oncol 19:2898–2904
Meyers CA, Wefel JS (2003) The use of the Mini-mental State Examination to assess cognitive functioning in cancer trails: no ifs, ands, buts, or sensitivity. J Clin Oncol 21:3557–3558. doi:10.1200/JCO.2003.07.080
Pereira J, Hanson J, Bruera E (1997) The frequency and clinical course of cognitive impairment in patients with terminal cancer. Cancer 79:835–842. doi:10.1002/(SICI)1097-0142(19970215)79:4<835::AID-CNCR21>3.0.CO;2-#
Peters M (1976) Prolonged practice of a simple motor task by preferred and non-preferred hands. Percept Mot Skills 42:447–450
Phillips B, Ball C, Sackett D, Badenoch D, Straus S, Haynes B, et al (1998) Oxford centre for evidence-based medicine levels of evidence. http://www.cebm.net/index.aspx?o=1047. Accessed 11 January 2007
Reitan RM (1958) Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 8:271–276
Santos CMC, Pimenta CAM, Nobre MRC (2007) The PICO strategy for the research question construction and evidence search. Rev Latino Am Enfermagem 15(3):508–511
Sjøgren P (1997) Psychomotor and cognitive functioning in cancer patients. Acta Anaesthesiol Scand 41:159–161
Sjøgren P, Banning A (1989) Pain, sedation and reaction time during long-term treatment of cancer patients with oral and epidural opioids. Pain 39:5–11. doi:10.1016/0304-3959(89)90168-1
Sjøgren P, Banning A, Christensen CB, Pedersen O (1994) Continuous reaction time after single dose, long-term oral and epidural opioid administration. Eur J Anaesthesiol 11:95–100
Sjøgren P, Olsen AK, Thomsen AB, Dalberg J (2000) Neuropsychological performance in cancer patients: the role of oral opioids, pain and performance status. Pain 86:237–245. doi:10.1016/S0304-3959(00)00248-7
Strömgren AS, Goldsmidt D, Groenvold M, Petersen MA, Jensen PT, Pedersen L et al (2002) Self-assessment in cancer patients referred to palliative care: a study of feasibility and symptom epidemiology. Cancer 94:512–520. doi:10.1002/cncr.10222
Stiefel FC, Holland JC (1991) Delirium in cancer patients. Int Psychogeriatr 3:333–336. doi:10.1017/S1041610291000789
Vainio A, Ollila J, Matikainen E, Rosenberg P, Kalso E (1995) Driving ability in cancer patients receiving long-term morphine analgesia. Lancet 346:667–670. doi:10.1016/S0140-6736(95)92281-4
Vardy J, Rourke S, Tannock IF (2007) Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research. J Clin Oncol 25:2455–2463. doi:10.1200/JCO.2006.08.1604
Ventafridda V, Ripamonti C, DeConno F, Tamburini M, Cassileth BR (1990) Symptom prevalence and control during cancer patients last days of life. J Palliat Care 6:7–11
Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA (2004) The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer 100(11):2292–2299. doi:10.1002/cncr.20272
Wilson B, Cockburn J, Baddeley A (1985) The Rivermead behavioural memory test. Thames Valley Test, Titchfield
Wood MM, Ashby MA, Somogyi AA, Fleming BG (1998) Neuropsychological and pharmacokinetic assessment of hospice inpatients receiving morphine. J Pain Symptom Manage 16:112–120. doi:10.1016/S0885-3924(98)00043-8
World Health Organization (2007) WHO’s pain relieve ladder. http://www.who.int/cancer/palliative/painladder/en/. Accessed 12 December 2007
Zacny JP (1995) A review of the effects of opioids on psychomotor and cognitive functioning in humans. Exp Clin Psychopharmacol 3(4):432–466. doi:10.1037/1064-1297.3.4.432
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kurita, G.P., Lundorff, L., Pimenta, C.A.d. et al. The cognitive effects of opioids in cancer: a systematic review. Support Care Cancer 17, 11–21 (2009). https://doi.org/10.1007/s00520-008-0497-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-008-0497-y